Bruce C. Cozadd
2015
In 2015, Bruce C. Cozadd earned a total compensation of $10.7M as Chairman and CEO at Jazz Pharmaceuticals, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $750,500 |
|---|---|
| Option Awards | $4,182,445 |
| Salary | $869,616 |
| Stock Awards | $4,870,279 |
| Other | $4,622 |
| Total | $10,677,462 |
Cozadd received $4.9M in stock awards, accounting for 46% of the total pay in 2015.
Cozadd also received $750.5K in non-equity incentive plan, $4.2M in option awards, $869.6K in salary and $4.6K in other compensation.
Rankings
In 2015, Bruce C. Cozadd's compensation ranked 448th out of 13,638 executives tracked by ExecPay. In other words, Cozadd earned more than 96.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 448 out of 13,638 | 97th |
Division Manufacturing | 146 out of 5,187 | 97th |
Major group Chemicals And Allied Products | 61 out of 1,857 | 97th |
Industry group Drugs | 48 out of 1,531 | 97th |
Industry Pharmaceutical Preparations | 38 out of 1,179 | 97th |
Source: SEC filing on June 20, 2017.
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2015.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019